Premium
Dengue virus in blood donations, Puerto Rico, 2005
Author(s) -
Mohammed Hamish,
Linnen Jeffrey M.,
MuñozJordán Jorge L.,
Tomashek Kay,
Foster Gregory,
Broulik Amy S.,
Petersen Lyle,
Stramer Susan L.
Publication year - 2008
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1111/j.1537-2995.2008.01771.x
Subject(s) - virology , dengue fever , dengue virus , antibody , viremia , biology , blood transfusion , blood donations , asymptomatic , flavivirus , immunology , flaviviridae , virus , medicine , transmission (telecommunications) , serology , viral disease , human immunodeficiency virus (hiv) , electrical engineering , engineering
BACKGROUND: A single instance of transfusion‐transmitted dengue infection has been reported. The high incidence of dengue in endemic countries, the high proportion of asymptomatic infection, and the median 5‐day viremia, however, suggest that transfusion‐associated dengue transmission may be more widespread than documented. STUDY DESIGN AND METHODS: The prevalence of dengue virus (DENV) RNA was determined in all blood donations to the American Red Cross in Puerto Rico from September 20 to December 4, 2005, using a specific type of nucleic acid amplification test called transcription‐mediated amplification (TMA). TMA‐positive donations were defined as those having two repeatedly reactive TMA results. TMA‐positive donations were tested by enzyme‐linked immunosorbent assay for immunoglobulin M (IgM) antibodies, by reverse transcription–polymerase chain reaction (RT‐PCR), and by viral culture. RESULTS: Twelve (0.07%) of 16,521 blood donations tested were TMA‐positive. Four were positive by RT‐PCR (DENV serotypes 2 and 3). Virus was cultured from 3 of 4 RT‐PCR–positive donations. One of the 12 TMA‐positive donations was IgM‐positive. Only 5 donations remained TMA‐positive when diluted 1:16, as is done for routine minipool screening for other transfusion‐transmissible viral infections (hepatitis C, human immunodeficiency, West Nile viruses [WNVs]). CONCLUSION: Nearly 1 in 1000 blood donations contained DENV RNA, and virus could be cultured from TMA‐positive donations, suggesting a transfusion transmission risk similar to that which existed in the United States for WNV before universal donation screening. Similar to WNV, IgM antibody screening is likely to be ineffective, and some potentially infectious donations will be missed by minipool screening. Transfusion transmission should be considered in patients with dengue after blood transfusion.